461 related articles for article (PubMed ID: 21517801)
21. The cost-effectiveness of 5-FU-SA in the treatment of actinic keratoses of the face and scalp in the UK secondary care setting.
Wojcik R; Lowin J; Vilardell D; Maeso S; Ruiz L; Lear JT; Morton C
J Med Econ; 2017 Mar; 20(3):221-227. PubMed ID: 27715356
[TBL] [Abstract][Full Text] [Related]
22. Modes of action of diclofenac 3%/hyaluronic acid 2.5% in the treatment of actinic keratosis.
Maltusch A; Röwert-Huber J; Matthies C; Lange-Asschenfeldt S; Stockfleth E
J Dtsch Dermatol Ges; 2011 Dec; 9(12):1011-7. PubMed ID: 21585654
[TBL] [Abstract][Full Text] [Related]
23. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
Berlin JM; Rigel DS
J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.
Nieves D; Puig-Peiró R; Ferrándiz C; Plazas MJ; Brosa M
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):539-43. PubMed ID: 25495775
[TBL] [Abstract][Full Text] [Related]
25. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
26. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
[TBL] [Abstract][Full Text] [Related]
27. Clinical, dermoscopic and immunohistochemical assessment of actinic keratoses and evaluation of the effectiveness of diclofenac therapy with immunohistochemical analysis.
Çayirli M; Köse O; Demiriz M
Arch Dermatol Res; 2013 Jul; 305(5):389-95. PubMed ID: 23397597
[TBL] [Abstract][Full Text] [Related]
28. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
Smith SR; Morhenn VB; Piacquadio DJ
J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
30. Treatment monitoring of 0.5% 5-fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy.
Malvehy J; Alarcon I; Montoya J; Rodríguez-Azeredo R; Puig S
J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):258-65. PubMed ID: 26538346
[TBL] [Abstract][Full Text] [Related]
31. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
Rivers JK; McLean DI
Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
[TBL] [Abstract][Full Text] [Related]
32. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study.
Jorizzo J; Weiss J; Vamvakias G
J Drugs Dermatol; 2006 Feb; 5(2):133-9. PubMed ID: 16485881
[TBL] [Abstract][Full Text] [Related]
33. Ingenol mebutate gel for actinic keratosis.
Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
[TBL] [Abstract][Full Text] [Related]
34. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
Dohil MA
J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
[TBL] [Abstract][Full Text] [Related]
35. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
[TBL] [Abstract][Full Text] [Related]
36. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
[TBL] [Abstract][Full Text] [Related]
37. Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.
Jarvis B; Figgitt DP
Am J Clin Dermatol; 2003; 4(3):203-13. PubMed ID: 12627996
[TBL] [Abstract][Full Text] [Related]
38. One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses.
Menter A; Vamvakias G; Jorizzo J
Cutis; 2008 Jun; 81(6):509-16. PubMed ID: 18666394
[TBL] [Abstract][Full Text] [Related]
39. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.
Martin GM; Stockfleth E
J Drugs Dermatol; 2012 May; 11(5):600-8. PubMed ID: 22527428
[TBL] [Abstract][Full Text] [Related]
40. New Topical Treatment Options for Actinic Keratosis: A Systematic Review.
Stockfleth E; Sibbring GC; Alarcon I
Acta Derm Venereol; 2016 Jan; 96(1):17-22. PubMed ID: 26068001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]